Literature DB >> 2591465

Paediatric drug prescribing. A comparison of Tenerife (Canary Islands, Spain) and Sweden.

E J Sanz1, U Bergman, M Dahlström.   

Abstract

The prescribing of medicines for ambulant children below 14 years of age has been compared between Tenerife (Spain) and Sweden. Data obtained from a random sample of 1327 children in a prospective study in Tenerife were compared with data from 3901 children in a Swedish survey linking diagnosis and therapy. Upper respiratory tract infection was the main diagnosis in both countries and antibiotics was the most frequently prescribed drug group (28.2% in Tenerife and 28.8% in Sweden). Half of the children in Sweden did not receive any medication, but only 10% of those in Tenerife did not receive a prescription. Children who received a prescription on average got 1.4 drugs in Sweden and 2.3 in Spain. Amongst the ten most commonly prescribed products in Sweden there were 11 active pharmacological principles as compared to 25 in Spain. These most frequently used preparations accounted for two thirds of all the prescriptions for children in Sweden and one third in Tenerife. In conclusion, drugs were significantly more often used to treat paediatric outpatients in Tenerife than in Sweden. The prescribing physician in Spain also chose a wider variety of drugs and more commonly used fixed combination products.

Entities:  

Mesh:

Year:  1989        PMID: 2591465     DOI: 10.1007/bf00609427

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Drug utilization by children in Tenerife Island.

Authors:  E J Sanz; J N Boada
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Differences between female and male children in the receipt of prescribed psychotropic and controlled-analgesic drugs. A five-year epidemiologic study.

Authors:  W A Ray; W Schaffner; C F Federspiel
Journal:  Med Care       Date:  1986-09       Impact factor: 2.983

3.  Adverse drug reactions in general pediatric outpatients.

Authors:  M S Kramer; T A Hutchinson; K M Flegel; L Naimark; R Contardi; D G Leduc
Journal:  J Pediatr       Date:  1985-02       Impact factor: 4.406

4.  [Use of antibiotics in primary care in Barcelona].

Authors:  L Drobnic; C Beni; J Canela; A Ezpeleta; E Castell
Journal:  Med Clin (Barc)       Date:  1984-04-07       Impact factor: 1.725

5.  Measurement of drug utilization in Sweden: methodological and clinical implications.

Authors:  U Bergman; F Sjöqvist
Journal:  Acta Med Scand Suppl       Date:  1984

6.  Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. WHO Drug Utilization Research Group (DURG).

Authors:  K Griffiths; D G McDevitt; M Andrew; I Baksaas; A Helgeland; J Jervell; P K Lunde; K Oydvin; I Agenäs; U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Drug therapy for ambulatory pediatric patients in 1979.

Authors:  D L Kennedy; M B Forbes
Journal:  Pediatrics       Date:  1982-07       Impact factor: 7.124

8.  Antibiotic-associated gastrointestinal symptoms in general pediatric outpatients.

Authors:  M S Kramer; T A Hutchinson; L Naimark; R Contardi; K M Flegel; D G Leduc
Journal:  Pediatrics       Date:  1985-09       Impact factor: 7.124

9.  Adverse drug reactions in paediatric outpatients.

Authors:  E Sanz; J Boada
Journal:  Int J Clin Pharmacol Res       Date:  1987

10.  Therapeutic traditions in Northern Ireland, Norway and Sweden: II. Hypertension. WHO Drug Utilization Research Group (DURG).

Authors:  K Griffiths; D G McDevitt; M Andrew; I Baksaas; A Helgeland; J Jervell; P K Lunde; K Oydvin; I Agenäs; U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more
  14 in total

1.  Drug utilisation patterns in the Third World.

Authors:  J S Bapna; C D Tripathi; U Tekur
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

2.  Paediatric prescribing in out-patient care. An example from Sri Lanka.

Authors:  G Tomson; V Diwan; I Angunawela
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Drug abuse in paediatric dentistry: a cross-sectional study.

Authors:  Meenakshi Sharma; Sandeep Tandon; Tina Chugh; Sanjay Sharma; Parmod Ps; Vishal Aggarwal; Nilotpal Kashyap
Journal:  J Clin Diagn Res       Date:  2014-03-15

4.  Drug related problems and off-label drug treatment in children as seen at a drug information centre.

Authors:  Elin Kimland; Ulf Bergman; Synnöve Lindemalm; Ylva Böttiger
Journal:  Eur J Pediatr       Date:  2006-12-29       Impact factor: 3.183

Review 5.  Drug use in non-hospitalized children.

Authors:  E J Sanz
Journal:  Pharm Weekbl Sci       Date:  1992-02-21

6.  Drug use of children in the community assessed through pharmacy dispensing data.

Authors:  E Schirm; P van den Berg; H Gebben; P Sauer; L De Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2000-11       Impact factor: 4.335

7.  Drug prescription in young children: results of a survey in France. Epicrèche Research Group.

Authors:  J P Collet; N Bossard; D Floret; J Gillet; D Honegger; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

8.  Adverse drug reactions and off-label drug use in paediatric outpatients.

Authors:  Benjamin Horen; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

9.  Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm.

Authors:  Mike Ufer; Anders Rane; Ake Karlsson; Elin Kimland; Ulf Bergman
Journal:  Eur J Clin Pharmacol       Date:  2003-02-22       Impact factor: 2.953

10.  Drug utilisation in outpatient children. A comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia).

Authors:  E Sanz; M A Hernández; S Ratchina; L Stratchounsky; M A Peiré; M Lapeyre-Mestre; B Horen; M Kriska; H Krajnakova; H Momcheva; D Encheva; I Martínez-Mir; V Palop
Journal:  Eur J Clin Pharmacol       Date:  2004-03-12       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.